5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.67▲ | 1.67▲ | 1.67▲ | 1.66▲ | 1.68▲ |
MA10 | 1.64▲ | 1.64▲ | 1.64▲ | 1.68▲ | 1.62▲ |
MA20 | 1.65▲ | 1.65▲ | 1.65▲ | 1.68▲ | 1.57▲ |
MA50 | 1.76▼ | 1.75▼ | 1.74▼ | 1.62▲ | 1.78▼ |
MA100 | 1.79▼ | 1.72▼ | 1.68▲ | 1.54▲ | 1.80▼ |
MA200 | 1.71▼ | 1.64▲ | 1.60▲ | 1.76▼ | 3.12▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.016▲ | 0.014▲ | 0.013▲ | -0.008▼ | 0.034▲ |
RSI | 53.162▲ | 53.069▲ | 51.576▲ | 52.477▲ | 50.741▲ |
STOCH | 98.718▲ | 98.718▲ | 87.607▲ | 17.935▼ | 51.031 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -78.571▼ | -62.658 |
CCI | 125.938▲ | 125.938▲ | 129.368▲ | -31.627 | 28.813 |
Thursday, August 14, 2025 05:17 AM
“The absence of any approved norovirus treatments or vaccines creates a substantial market opportunity for Cocrystal,” said James Martin, Cocrystal's CFO and co-CEO. “ With 685 million global cases ...
|
Wednesday, August 06, 2025 12:29 AM
BOTHELL, WA, USA I August 05, 2025 I Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the presentation of favorable safety and tolerability data from a ...
|
Saturday, April 05, 2025 02:06 PM
COCRYSTAL PHARMA Hedge Fund Activity We have seen 8 institutional investors add shares of COCRYSTAL PHARMA stock to their portfolio, and 5 decrease their positions in their most recent quarter ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.68 | 1.70 | 1.6248 | 1.695 | 38,701 |
14/08/25 | 1.67 | 1.68 | 1.61 | 1.68 | 18,803 |
13/08/25 | 1.65 | 1.71 | 1.63 | 1.68 | 36,794 |
12/08/25 | 1.59 | 1.67 | 1.59 | 1.65 | 18,506 |
11/08/25 | 1.60 | 1.6264 | 1.59 | 1.60 | 35,661 |
08/08/25 | 1.65 | 1.6738 | 1.60 | 1.62 | 18,133 |
07/08/25 | 1.71 | 1.71 | 1.56 | 1.65 | 73,900 |
06/08/25 | 1.66 | 1.7428 | 1.66 | 1.67 | 56,365 |
05/08/25 | 1.85 | 1.903 | 1.65 | 1.65 | 213,738 |
04/08/25 | 1.96 | 2.19 | 1.79 | 1.94 | 473,007 |
|
|
||||
|
|
||||
|
|